C.A.P.A.B.L.E. (Cross-Training and Physical Activity: A Better Life Experience Study) (CAPABLE)

April 18, 2023 updated by: Jennifer Beebe-Dimmer, PhD, Barbara Ann Karmanos Cancer Institute

Does High-Intensity Functional Training Improve Patient Movement and Quality of Life? A Pilot Study of Cross-Training in Cancer Survivors

This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors.

Study Overview

Status

Recruiting

Conditions

Detailed Description

A 12-week pilot intervention study introducing a high-intensity functional training program to 100 cancer survivors and evaluate the effects of this program on patient quality of life, functional capacity, and body composition. Response rates will be determined using various recruitment methods and estimate differences in response rates by patient characteristics including race, gender and age. Barriers to participation in the program in contacted patients who do not enroll as well as patients who enroll and do not complete the program will be described, as will participant satisfaction with enrolled participants who complete the program. The goal of this pilot study is to help refine the recruitment and program methods for a larger intervention study to test the superiority of a high-intensity interval functional training program compared with current American Cancer Society guidelines in improving functional capacity, body composition and patient reported quality of life.

Surveys will be completed by each participant weekly and physical assessments will be completed monthly.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Michigan
      • Detroit, Michigan, United States, 48201
        • Recruiting
        • Barbara Ann Karmanos Cancer Institute
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18 years or older at time of program recruitment
  • Diagnosed with an invasive cancer
  • Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist).
  • Available transportation to and from the facility on session days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: A 12-week pilot intervention study introducing a high-intensi
Participants will begin a 12-week high-intensity functional training program conducted at CrossFit® in the D, located in downtown Detroit, Northville Athletix in Northville and Five Lakes CrossFit® in Farmington Hills.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Enrollment rates
Time Frame: Baseline
Enrollment rates will be calculated among those who respond to notices about the study and adherence to the program among those who enroll and to describe reported barriers to participation among respondents who do not ultimately enroll
Baseline
Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program
Time Frame: Baseline to 12 weeks
Physical measures of strength will be assessed by a certified trainer. To assess strength improvements deadlifts (lifting weights from floor to waist) will be performed in 10 lb. increments. A circuit will also be done with strength measures including sit ups and push ups.
Baseline to 12 weeks
Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program
Time Frame: Baseline to 12 weeks
Physical measures of flexibility will be assessed by a certified trainer. To assess flexibility sit ups, squats and push up level (floor, knees, on an elevated bar, etc) will be recorded.
Baseline to 12 weeks
Change in functional performance and variability in functional performance among adult cancer survivors enrolled in a high-intensity functional training program
Time Frame: Baseline to 12 weeks
Physical measures of cardiovascular strength will be assessed by a certified trainer. To assess cardiovascular strength maximum effort on a stationary bike will be recorded. Additionally, in the circuit, a maximum effort on a rowing machine will be recorded.
Baseline to 12 weeks
Change in self-reported health-related quality of life (HRQOL) and variability using the FACT questionnaire
Time Frame: Baseline to 12 weeks
Quality of Life will be measured using the Functional Assessment of Cancer Therapy: General (FACT), developed by Dr. David Cella. The FACT-G is 27 items assessing physical, social/ family, emotional and functional well-being. The survey uses a five-point scale from 0 (not at all) to 4 (very much). Scoring the FACT-G is performed through a sum of item scores. Higher scores indicate a better health state.
Baseline to 12 weeks
Change in Body Composition
Time Frame: Baseline to 12 weeks
Changes in weight in kg
Baseline to 12 weeks
Change in Body Composition
Time Frame: Baseline to 12 weeks
Changes in body fat percentage
Baseline to 12 weeks
Change in Body Composition
Time Frame: Baseline to 12 weeks
Changes in visceral fat percentage
Baseline to 12 weeks
Change in Body Composition
Time Frame: Baseline to 12 weeks
Changes in muscle mass percentage
Baseline to 12 weeks
Change in Body Composition
Time Frame: Baseline to 12 weeks
Changes in body mass index (BMI) - Weight and height will be combined to report BMI in kg/ m2
Baseline to 12 weeks
Change in Body Composition
Time Frame: Baseline to 12 weeks
Changes in resting metabolism value
Baseline to 12 weeks
Change in Motivation
Time Frame: Baseline to 12 weeks
Motivation to exercise will be collected via a survey
Baseline to 12 weeks
Satisfaction with the Program
Time Frame: 12 weeks
Satisfaction with the program will be collected via a survey
12 weeks
Program Adherence
Time Frame: 12 weeks
Program adherence will be calculated based on how many sessions each participant attended in the 13 week program, 36 session design.
12 weeks
Height
Time Frame: Baseline
Height will be collected in meters to use in the calculation of Body Mass Index
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2018

Primary Completion (Anticipated)

April 30, 2024

Study Completion (Anticipated)

April 30, 2024

Study Registration Dates

First Submitted

November 15, 2018

First Submitted That Met QC Criteria

November 20, 2018

First Posted (Actual)

November 23, 2018

Study Record Updates

Last Update Posted (Actual)

April 19, 2023

Last Update Submitted That Met QC Criteria

April 18, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2018-091

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Survivors

Clinical Trials on 12 week pilot intervention study.

3
Subscribe